Sign Up to like & get
recommendations!
1
Published in 2023 at "Cancers"
DOI: 10.3390/cancers15113010
Abstract: Simple Summary Around 30% of patients with stage III non-small cell lung cancer (NSCLC) receiving radical chemoradiotherapy will develop symptomatic brain metastases (BM) during the disease course. Identifying risk factors for BM can help improve…
read more here.
Keywords:
stage iii;
radically treated;
radiomics features;
patients radically ... See more keywords